Gastroenteritis vaccine success

Adding rotavirus to the childhood immunisation programme could prevent gastroenteritis episodes in the first two years of life, say Finnish researchers.

Each year in the EU, rotavirus is estimated to cause more than 200 deaths and nearly 700,000 out-patient appointments among the under-fives.

The study involved 3,994 children aged six to 14 weeks. Two-thirds were given two oral doses of human rotavirus vaccine. All were followed-up for an average of 17 months. Stool samples were collected in any bouts of gastroenteritis and tested for the presence of rotavirus.

Within six months of the first dose of vaccine being given, the researchers found an efficacy of 87.1 per cent in the treatment arm versus placebo. Two doses of rotavirus vaccine gave 78.9 per cent protection against rotavirus gastroenteritis of any severity.

Lancet 2007; 370: 1,757-63

Comment below and tell us what you think

 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Most children could be removed from shielded patient list, deputy CMO suggests

Most children could be removed from shielded patient list, deputy CMO suggests

Most children could be removed from the shielded patient list in a future wave of...

GPs can provide some care for shielded patients in clinical settings, NHS England confirms

GPs can provide some care for shielded patients in clinical settings, NHS England confirms

GPs can provide care to shielded patients in 'infection-controlled clinical settings'...

How digital assistants can help patients manage their health and wellbeing

How digital assistants can help patients manage their health and wellbeing

A project in Staffordshire has shown how practices can make use of digital technology...

Coronavirus: Key guidance GPs need to know about COVID-19

Coronavirus: Key guidance GPs need to know about COVID-19

GPonline provides an overview of the key guidance relating to coronavirus, including...

Fair death-in-service deal for locums vital before second COVID-19 wave, warns BMA

Fair death-in-service deal for locums vital before second COVID-19 wave, warns BMA

The government must do ‘the right thing’ and secure adequate death-in-service benefits...

GP workload fears over antibody testing rollout for 'no clinical benefit'

GP workload fears over antibody testing rollout for 'no clinical benefit'

GP practices are being contacted by patients asking for antibody tests as the government...